Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 12, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 18, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001225208-26-002015
Filed / recorded
Feb 18, 2026, 12:06 AM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
BOSTON SCIENTIFIC CORP
Issuer CIK
885725
Ticker
BSX
Reporting person
Joseph Michael Fitzgerald
Relationship
Officer
Officer title
EVP & Group Pres, Cardiology
Security
Restricted Stock Units
Table
Derivative (Table II)
Transaction date
Feb 12, 2026
Transaction code
M
Shares / units
3,462
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
6,924
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.